Nxera Pharma Co Ltd (SOLTF)
9.304
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Nxera Pharma Gross Profit Margin (Quarterly): 76.00% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.00% |
| September 30, 2023 | 66.14% |
| June 30, 2023 | 88.94% |
| March 31, 2023 | 90.24% |
| December 31, 2022 | 97.32% |
| September 30, 2022 | 96.62% |
| June 30, 2022 | 81.84% |
| March 31, 2022 | 74.26% |
| December 31, 2021 | 97.91% |
| September 30, 2021 | 59.10% |
| June 30, 2021 | 88.47% |
| March 31, 2021 | 81.28% |
| December 31, 2020 | 94.77% |
| September 30, 2020 | 89.72% |
| June 30, 2020 | 88.33% |
| March 31, 2020 | 84.94% |
| December 31, 2019 | 87.42% |
| September 30, 2019 | 92.19% |
| June 30, 2019 | 90.67% |
| March 31, 2019 | 93.21% |
| December 31, 2018 | 68.66% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 99.02% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 99.15% |
| December 31, 2014 | |
| September 30, 2014 | 93.01% |
| June 30, 2014 | 90.25% |
| March 31, 2014 | 71.15% |
| December 31, 2013 | 95.07% |
| September 30, 2013 | 91.22% |
| June 30, 2013 | 44.54% |
| March 31, 2013 | 58.93% |
| December 31, 2012 | 78.67% |
| September 30, 2012 | 97.75% |
| June 30, 2012 | 38.33% |
| March 31, 2012 | 4.42% |
| December 31, 2011 | -9.21% |
| September 30, 2011 | 83.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.10%
Minimum
Sep 2021
97.91%
Maximum
Dec 2021
85.59%
Average
88.47%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 65.85% |
| PeptiDream Inc | 48.45% |
| Stemcell Holdings Inc | -- |
| Healios KK | -- |
| AnGes Inc | 14.39% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -11.71% |
| Return on Assets | -5.88% |
| Return on Invested Capital | -6.81% |
| Profit Margin (Quarterly) | -2.85% |
| Operating Margin (Quarterly) | -21.04% |
| Return on Net Operating Assets | -12.64% |